In community settings in particular, there are simply not enough open positions for all of the pharmacy graduates as well as those changing jobs due to layoffs and other reasons.
Some pharmacy experts and veterans blame DIR fees and other expenses that are harming pharmacies’ bottom line, while others say there are just too many retail pharmacies and not enough pharmacists qualified to work in specialty areas such as oncology and endocrinology.
“Pharmacy as a whole is challenged by PBM tactics that interfere with pharmacists’ ability to treat patients and make it more difficult for pharmacies to stay afloat. In addition to expanding pharmacists’ scope of practice, reining in PBMs’ tactics would assist pharmacy’s decision-making about staffing abilities and whether to expand or even maintain a pharmacy business,” says Andrea Pivarunas, director of public affairs for the National Community Pharmacy Association (NCPA).
“Various players have been taking money out of the drug distribution system for many years, but it has been much worse in past two to three years largely, I believe, due to DIR fees,” says Lucinda Maine, RPh, executive vice president and CEO of the American Association of Colleges of Pharmacy (AACP).
In addition, the competitive landscape has changed over the last 25 years, according to Maine. “It’s possible that there wasn’t enough business to put a pharmacy on every corner [in certain cities]. And then you add in mail order… and online retailers have dented [brick-and-mortar] business,” she says.
Pharmacy closures and staff layoffs can also be attributed to viewing pharmacists as only drug dispensers. “We haven’t yet developed the consistent patterns of compensation for pharmacist services—the value-added services that pharmacists can and should be providing the public,” Maine says.
Plus, the demand for pharmacist and tech jobs, and the required pharmacy schools to train them, has boomeranged the shortage of pharmacists in 2000. The pace of new school openings between 2001 and 2018 was “dizzying,” including the establishment of multiple satellite sites and branch campuses, Maine wrote in a commentary in the American Journal of Pharmacy Education.
Read More: The Top 10 Best States to Be a Pharmacist
The number of pharmacy schools and colleges soared from 83 in 2002 to 142 in 2018. The number of graduates in spring 2018 numbered slightly more than 14,500. In addition, more than 325,000 pharmacists were licensed in the United States in 2017, according to the National Association of Boards of Pharmacy (NABP).
Some pharmacy school graduates were so upset about their job prospects after graduation that they urged the public to sign a petition, “Halt New PharmD Accreditation to 2030.” It was signed by almost 10,000 additional petitioners in just a week, Maine says.
“The fundamental premise is that the job market for pharmacists can no longer accommodate the number of PharmD graduates. They specifically asked the American Association of Colleges of Pharmacy, the Accreditation Council for Pharmacy Education, and the American Pharmacists Association to take action to prevent the opening of more new schools,” Maine writes in the commentary.
Continue reading on page 2...